Zolmitriptan CAS NO.139264-17-8
We are a manufacturer based in China. We specialize in providing high-quality Zolmitriptan CAS NO.139264-17-8 for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.
Category：Active Pharmaceutical Ingredients Own Brand：MT /MOQ:100KG /From China/ B2B only.
Introduction
Catalog ID80017035
CAS NO.139264-17-8
Purity 95%
MDL NumberMFCD00871503
EINEC Molecular Formula C16H21N3O2
Molecular Weight 287.3568
| Aspect | Details |
|---|---|
| Definition | Zolmitriptan is a selective 5-hydroxytryptamine (5-HT) 1B/1D receptor agonist used to treat acute migraine attacks. |
| Mechanism of Action | – Binds with high affinity to 5-HT1B/1D receptors, causing vasoconstriction of intracranial blood vessels and inhibiting the release of pro-inflammatory neuropeptides.<br>- Penetrates the blood-brain barrier, providing both peripheral and central effects. |
| Clinical Uses | – FDA-approved for treating acute migraine with or without aura.<br>- Available in tablet, orally disintegrating tablet, and nasal spray forms.<br>- Off-label use for preventing menstrual migraines. |
| Pharmacokinetics | – Absorption: Rapidly absorbed orally, with linear kinetics over the dose range of 2.5 to 50 mg.<br>- Distribution: Plasma protein binding is 25%, with a volume of distribution of 7 L/kg.<br>- Metabolism: Primarily metabolized by CYP1A2 and MAO-A into an active N-desmethyl metabolite.<br>- Elimination: Elimination half-life is approximately 3 hours, primarily excreted renally. |
| Side Effects | – Common: Dizziness, somnolence, paresthesia, dry mouth.<br>- Serious: Hypersensitivity reactions, serotonin syndrome. |
| Contraindications | – Hypersensitivity to zolmitriptan.<br>- Ischemic heart disease, uncontrolled hypertension. |
| Storage Conditions | Store at room temperature, away from moisture and light. |
| Formulations | – Tablets: 2.5 mg (yellow) and 5 mg (pink).<br>- Orally Disintegrating Tablets: 2.5 mg and 5 mg.<br>- Nasal Spray. |
| Research Applications | Investigated for its efficacy and safety in treating migraine attacks, with studies demonstrating its effectiveness in reducing headache severity and associated symptoms. |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.
Inquiry
Factory & Shipment
